Erratum: GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils

被引:0
|
作者
Nariman A B Balenga
Elma Aflaki
Julia Kargl
Wolfgang Platzer
Ralf Schröder
Stefanie Blättermann
Evi Kostenis
Andrew J Brown
Akos Heinemann
Maria Waldhoer
机构
[1] Institute of Experimental and Clinical Pharmacology,Department of Screening and Compound Profiling
[2] Medical University of Graz,undefined
[3] Institute of Molecular Biology and Biochemistry,undefined
[4] Medical University of Graz,undefined
[5] Section Molecular,undefined
[6] Cellular and Pharmacobiology,undefined
[7] Institute for Pharmaceutical Biology,undefined
[8] University of Bonn,undefined
[9] GlaxoSmithKline,undefined
[10] Medicines Research Centre,undefined
来源
Cell Research | 2011年 / 21卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Correction to: Cell Research (2011) 21:1452-1469. doi:10.1038/cr.2011.60; published online 5 April 2011 The authors apologize for the wrong β-actin blot in Figure 4Ai. The Figure 4Ai with the correct β-actin blot is as follows: The authors would also like to update the current addresses for two of the authors in this corrigendum.
引用
收藏
页码:1641 / 1641
相关论文
共 50 条
  • [1] GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
    Balenga, Nariman A. B.
    Aflaki, Elma
    Kargl, Julia
    Platzer, Wolfgang
    Schroeder, Ralf
    Blaettermann, Stefanie
    Kostenis, Evi
    Brown, Andrew J.
    Heinemann, Akos
    Waldhoer, Maria
    CELL RESEARCH, 2011, 21 (10) : 1452 - 1469
  • [2] GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
    Nariman A B Balenga
    Elma Aflaki
    Julia Kargl
    Wolfgang Platzer
    Ralf Schröder
    Stefanie Blättermann
    Evi Kostenis
    Andrew J Brown
    Akos Heinemann
    Maria Waldhoer
    Cell Research, 2011, 21 : 1452 - 1469
  • [3] GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils (vol 21, pg 1452, 2011)
    Balenga, Nariman A. B.
    Aflaki, Elma
    Kargl, Julia
    Platzer, Wolfgang
    Schroeder, Ralf
    Blaettermann, Stefanie
    Kostenis, Evi
    Brown, Andrew J.
    Heinemann, Akos
    Waldhoer, Maria
    CELL RESEARCH, 2011, 21 (11) : 1641 - 1641
  • [4] GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?
    Nevalainen, Tapio
    Irving, Andrew J.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (08) : 799 - 813
  • [5] The orphan receptor GPR55 is a novel cannabinoid receptor
    Ryberg, E.
    Larsson, N.
    Sjoegren, S.
    Hjorth, S.
    Hermansson, N-O
    Leonova, J.
    Elebring, T.
    Nilsson, K.
    Drmota, T.
    Geasley, P. J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (07) : 1092 - 1101
  • [6] Pharmacological characterization of GPR55, a putative cannabinoid receptor
    Sharir, Haleli
    Abood, Mary E.
    PHARMACOLOGY & THERAPEUTICS, 2010, 126 (03) : 301 - 313
  • [7] GPR55: a new member of the cannabinoid receptor clan?
    Pertwee, R. G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (07) : 984 - 986
  • [8] Off-Target Cannabinoid Effects Mediated by GPR55
    Henstridge, Christopher M.
    PHARMACOLOGY, 2012, 89 (3-4) : 179 - 187
  • [9] The novel cannabinoid receptor GPR55, inhibits cholangiocarcinoma growth
    DeMorrow, Sharon
    Frampton, Gabriel
    Quinn, Matthew
    Huang, Li
    FASEB JOURNAL, 2011, 25
  • [10] Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
    Kapur, Ankur
    Zhao, Pingwei
    Sharir, Haleli
    Bai, Yushi
    Caron, Marc G.
    Barak, Larry S.
    Abood, Mary E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (43) : 29817 - 29827